Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN132,34132,362,27
Msft-1,12
Nokia6,9526,96-3,47
IBM-0,88
Mercedes-Benz Group AG40,0740,085-0,87
PFE0,10
17.11.2026 9:29:53
Indexy online
AD Index online
select
AD Index online
 

  • 16.11.2026
SCI (SCI, NY Consolidated)
Závěr k 16.11.2026 Změna (%) Změna (USD) Objem obchodů (USD)
75,81 1,11 0,83 60 427 740
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 17.11.2026
Popis společnosti

Business Summary: Service Corporation International is a provider of funeral, cemetery and cremation services, as well as final arrangement planning in advance. Its diversified portfolio of brands provides families and individuals a range of choices to meet their needs, from simple cremations to full life celebrations and personalized remembrances. Its Dignity Memorial brand is a transcontinental brand of deathcare products and services. It owns and operates over 1,493 funeral service locations and 496 cemeteries (of which 308 are combination locations) in 44 states, eight Canadian provinces, the District of Columbia, and Puerto Rico. Its funeral service and cemetery operations consist of funeral service locations, cemeteries, funeral service/cemetery combination locations, crematoria, and other related businesses. Its cemeteries provide cemetery property interment rights, including developed lots, lawn crypts, mausoleum spaces, niches, and other cremation memorialization and interment options.
Financial Summary: BRIEF: For the nine months ended 30 September 2026, Service Corporation International revenues increased 3% to $3.31B. Net income increased 5% to $401.9M. Revenues reflect Funeral segment increase from $574.1M to $1.84B, Cemetery segment increase from $484M to $1.47B, United States segment increase from $1.01B to $3.15B, Canada segment increase from $48M to $158.2M. Net income benefited from Restructuring Charges decrease from $2M (expense) to $0K.



  • Poslední aktualizace: 17.11.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Executive DirectorPascal Soriot6601.10.201201.10.2012
Chief Financial Officer, Executive DirectorAradhana Sarin-01.08.202101.08.2021
Chief Human Resources Officer, Chief Compliance Officer, General CounselJeffrey Pott-01.01.2009
Executive Vice President - Bio Pharmaceuticals Research and DevelopmentSharon Barr-
Executive Vice President - Global Operations, Information Technology and Chief Sustainability OfficerPam Cheng-
Executive Vice President - Bio Pharmaceuticals Business UnitRuud Dobber61
Executive Vice President - Oncology Haematology Business UnitDavid Fredrickson51
Executive Vice President - Oncology Haematology Research and DevelopmentSusan Galbraith-
Executive Vice President, InternationalIskra Reic-04.12.2024
Chief Strategy Officer, Chief Executive Officer - AlexionMarc Dunoyer7301.08.202101.01.2013